Molecular and Cellular Characterization of Skull Base Tumors

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT03759717
Status
Recruiting

Conditions

  • Cellular Pathology
  • Skull Base Neoplasm

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observation — OTHER
    Understanding the biology of skull base tumors will teach the investigators about the genesis and/or mechanisms of treatment resistance. The investigators hope to ultimately identify new targets which will add to the armamentarium by which to treat these tumors.

Study Details

The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.

Key Dates

Start date
Oct 3, 2018
Status verified
Sep 2025
Primary completion
Oct 3, 2028
Completion
Oct 3, 2028

Study Design

Enrollment
4,000 participants (estimated)

Primary Outcome Measure

Patient overall survival will be measured and reported. [ Time Frame: Through study completion, an average of 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Pittsburgh Medical CenterPittsburghPennsylvania15213
Benita Valappil, MPH
412-864-1744

Find similar trials in Pittsburgh, PA